Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Lymphocyte Activation Gene-3 (CD223) Regulates the Size of the Expanding T Cell Population Following Antigen Activation In Vivo
2004
CD4+ Tregs and immune control
2004 StandoutNobel
Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3
2007
LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
2009
Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi's Sarcoma Cells
1999
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Lymphangiogenesis and cancer metastasis
2002 Standout
The negative regulatory function of the lymphocyte‐activation gene‐3 co‐receptor (CD223) on human T cells
2005
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
2007 Standout
T cell exhaustion
2011 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
AP-1: a double-edged sword in tumorigenesis
2003 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Mesenchymal stem cells in health and disease
2008 Standout
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
2007 StandoutNature
Mucosal immunity and vaccines
2005 Standout
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
How regulatory T cells work
2008 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell–cell contacts
2001
LAG-3 in Cancer Immunotherapy
2010
Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses
1999
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
The CD4-like molecule LAG-3, biology and therapeutic applications
2010
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
2005
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)
2002
Molecular and cellular insights into T cell exhaustion
2015 Standout
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
2016
Role of LAG-3 in Regulatory T Cells
2004
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients
2005 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
2013
The CD4‐related molecule, LAG‐3 (CD223), regulates the expansion of activated T cells
2003
Biochemical Analysis of the Regulatory T Cell Protein Lymphocyte Activation Gene-3 (LAG-3; CD223)
2004
Regulatory T Cells: Mechanisms of Differentiation and Function
2007 Standout
Genetic and epigenetic basis of Treg cell development and function: from a FoxP3‐centered view to an epigenome‐defined view of natural Treg cells
2014 StandoutNobel
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Searching for Interferon-Induced Genes That Inhibit Hepatitis B Virus Replication in Transgenic Mouse Hepatocytes
2002
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
2006
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
CD3/TCR Complex-Associated Lymphocyte Activation Gene-3 Molecules Inhibit CD3/TCR Signaling
1998
c- fos -induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
1999
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
CD4+regulatory cells as a potential immunotherapy
2005 StandoutNobel
Maturation and Activation of Dendritic Cells Induced by Lymphocyte Activation Gene-3 (CD223)
2002
CD4+ Tregs and immune control
2004 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Regulatory roles of IL-10–producing human follicular T cells
2019 StandoutNobel
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
2002
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
2006
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Negative Regulation of T Cell Homeostasis by Lymphocyte Activation Gene-3 (CD223)
2005
Works of S. Donini being referenced
A highly precise reporter gene bioassay for type I interferon
1996
Cloning of Murine LAG-3 by Magnetic Bead Bound Homologous Probes and PCR (GENE-CAPTURE PCR)
1996
The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposiʼs sarcoma-derived cells and a new immortalized Kaposiʼs sarcoma cell line
1997
Characterization of the major histocompatibility complex class II binding site on LAG-3 protein
1997